PHILADELPHIA, PA — Virion Therapeutics, LLC announced that new clinical data from its VRON-0200 program for chronic Hepatitis ...

Volunteers at three dental clinics on Church-operated high school campuses in Samoa, Tonga and Kiribati are serving the ...

Getting your Trinity Audio player ready... From Odyssey for Democracy The president and founder of local nonprofit Odyssey ...

Oral Presentation to be Featured on Initial Results of a First-in-Human Study for a Promising Targeted Therapy for ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the first interim analysis results of a phase III clinical trial of anbenitamab injection (KN026), independently developed by the Company and ...

Topline results and additional data from the pivotal SynAIRgy and LunAIRo Phase 3 studies – the largest clinical program of an investigational ...

Trial is evaluating ciforadenant as a potential first line therapy for metastatic renal cell cancer (RCC) in combination with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1) Interim data shows ...

A higher proportion of patients with pulmonary sarcoidosis were steroid-free after 48 weeks of treatment with efzofitimod vs.

Presentation at AAO 2025 part of ongoing NEW DAY data dissemination at medical meetings ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

AI-powered histopathology demonstrates predictive value for immunotherapy outcomes in pMMR mCRC, advanced ccRCC, and NSCLC with data featured in both oral and poster presentations SEOUL, South Korea, ...